Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL) (NCT02570542)

🧪 Interventions in This Study

• Plerixafor (DRUG)
• carmustine, etoposide, cytarabine, melphalan (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (14 Sites)

• University of Nebraska Medical Center — Omaha, Nebraska
• Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up Only) — Basking Ridge, New Jersey
• Memorial Sloan Kettering Monmouth (Consent and Follow up Only) — Middletown, New Jersey
• Memorial Sloan Kettering Bergen (Consent and Follow Up Only) — Montvale, New Jersey
• Memorial Sloan Kettering Commack (Consent and Follow-up Only) — Commack, New York
• Memorial Sloan Kettering Westchester — Harrison, New York
• Northwell Health (Data collection only) — Manhasset, New York
• Memorial Sloan Kettering Cancer Center — New York, New York
• Columbia University — New York, New York
• University of Rochester Medical Center — Rochester, New York
• Memorial Sloan Kettering Nassau (Consent and Follow up Only) — Uniondale, New York
• Tennessee Oncology — Nashville, Tennessee
• Texas Transplant Institute — San Antonio, Texas
• Medical College of Wisconsin — Milwaukee, Wisconsin

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Diffuse Large B-cell Lymphoma (DLBCL)

• Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30) — Houston, Texas
• The CARDIOPROTECT Trial — Boston, Massachusetts
• A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma — Scottsdale, Arizona
• A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP — Rochester, New York

Explore by condition: All Diffuse Large B-cell Lymphoma (DLBCL) clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.